Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 18 04:00PM ET
8.43
Dollar change
-0.30
Percentage change
-3.44
%
IndexRUT P/E- EPS (ttm)-0.05 Insider Own17.27% Shs Outstand54.39M Perf Week-5.70%
Market Cap458.51M Forward P/E- EPS next Y-1.68 Insider Trans-0.45% Shs Float45.00M Perf Month2.06%
Income-3.04M PEG- EPS next Q-0.41 Inst Own63.99% Short Float8.53% Perf Quarter8.91%
Sales119.04M P/S3.85 EPS this Y-150.69% Inst Trans0.50% Short Ratio8.20 Perf Half Y15.48%
Book/sh6.28 P/B1.34 EPS next Y-11.30% ROA-0.76% Short Interest3.84M Perf Year-11.36%
Cash/sh7.35 P/C1.15 EPS next 5Y- ROE-1.09% 52W Range6.06 - 11.72 Perf YTD-0.12%
Dividend Est.- P/FCF55.71 EPS past 5Y- ROI-0.80% 52W High-28.07% Beta0.97
Dividend TTM- Quick Ratio5.64 Sales past 5Y355.29% Gross Margin96.17% 52W Low39.11% ATR (14)0.40
Dividend Ex-Date- Current Ratio5.64 EPS Y/Y TTM-100.71% Oper. Margin-14.32% RSI (14)51.83 Volatility6.03% 4.20%
Employees162 Debt/Eq0.14 Sales Y/Y TTM-37.58% Profit Margin-2.56% Recom1.30 Target Price17.56
Option/ShortYes / Yes LT Debt/Eq0.12 EPS Q/Q-106.74% Payout0.00% Rel Volume0.75 Prev Close8.73
Sales Surprise105.70% EPS Surprise54.47% Sales Q/Q-87.03% EarningsMay 13 AMC Avg Volume468.24K Price8.43
SMA203.74% SMA501.17% SMA2004.92% Trades Volume350,615 Change-3.44%
Date Action Analyst Rating Change Price Target Change
Mar-26-24Initiated Guggenheim Buy $22
Mar-19-24Initiated H.C. Wainwright Buy $30
Mar-07-24Initiated Citigroup Buy $16
Jan-02-24Upgrade Wells Fargo Equal Weight → Overweight $14
May-10-23Initiated Truist Buy $18
Mar-10-23Initiated Oppenheimer Outperform $14
Oct-07-21Upgrade Robert W. Baird Neutral → Outperform $6 → $9
Feb-26-21Downgrade Robert W. Baird Outperform → Neutral $18 → $6
Feb-03-21Downgrade Wedbush Outperform → Neutral $6
Feb-03-21Downgrade BTIG Research Buy → Neutral
Jul-09-24 04:01PM
Jun-13-24 04:01PM
07:00AM
May-16-24 07:00AM
May-14-24 08:16AM
06:27AM Loading…
06:27AM
03:03AM
May-13-24 08:56PM
05:10PM
04:09PM
04:01PM
May-08-24 06:00AM
May-06-24 07:00AM
Apr-22-24 04:30PM
Apr-16-24 07:00AM
03:00AM Loading…
Mar-30-24 03:00AM
Mar-26-24 04:01PM
Mar-13-24 07:00AM
Mar-09-24 01:09PM
Feb-29-24 11:09AM
09:54AM
Feb-28-24 04:41PM
04:32PM
04:01PM
Feb-26-24 07:00AM
Feb-21-24 07:00AM
Feb-20-24 07:00AM
Feb-07-24 07:00AM
Jan-11-24 10:09PM
Jan-04-24 10:45PM
04:14PM Loading…
04:14PM
Jan-03-24 11:15AM
07:00AM
Jan-02-24 04:07PM
01:51PM
10:46AM
07:36AM
07:14AM
07:14AM
07:09AM
07:00AM
Dec-17-23 12:03PM
Dec-08-23 10:13AM
Dec-07-23 06:10AM
Dec-06-23 07:00AM
Nov-07-23 10:16AM
Nov-06-23 05:22PM
04:17PM
04:01PM
Oct-30-23 07:00AM
Sep-25-23 07:00AM
Sep-07-23 04:01PM
Aug-30-23 07:00AM
Aug-22-23 08:14AM
Aug-08-23 04:01PM
Aug-07-23 08:00AM
Aug-03-23 08:25AM
07:17AM
07:00AM
Aug-02-23 07:00AM
Jul-27-23 07:00AM
Jul-14-23 05:40AM
Jul-11-23 08:53PM
04:01PM
Jul-10-23 08:00AM
Jun-21-23 04:49AM
Jun-15-23 06:30AM
Jun-01-23 07:52PM
07:00AM
May-25-23 12:29PM
May-18-23 06:00AM
May-09-23 08:35AM
07:37AM
07:00AM
06:55AM
May-05-23 06:08AM
May-03-23 10:25PM
May-02-23 04:30PM
07:00AM
Apr-08-23 09:12AM
Mar-28-23 07:00AM
Mar-12-23 08:04AM
Mar-08-23 03:03AM
Mar-07-23 08:25AM
07:00AM
Mar-06-23 07:00AM
Feb-28-23 07:00AM
Feb-13-23 08:00AM
Feb-10-23 06:23AM
Feb-09-23 07:00AM
Feb-03-23 04:36AM
Feb-02-23 06:43AM
Jan-27-23 07:00AM
Jan-24-23 04:01PM
06:15AM
Jan-20-23 12:08PM
09:55AM
Jan-09-23 01:23PM
09:15AM
08:15AM
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandrock AlfredPresident and CEOApr 02 '24Sale9.8612,115119,454322,839Apr 03 04:10 PM
Swartz RobinChief Operating OfficerApr 02 '24Sale9.881,35713,407117,004Apr 03 04:13 PM
Sandrock AlfredPresident and CEOFeb 21 '24Sale7.4613,03397,226334,954Feb 22 04:34 PM
Swartz RobinChief Operating OfficerFeb 21 '24Sale7.453,96629,547118,361Feb 22 04:36 PM
PFREUNDSCHUH PETER P.Chief Financial OfficerFeb 21 '24Sale7.463,76428,079175,669Feb 22 04:32 PM
Carter Todd AlfredChief Scientific OfficerFeb 21 '24Sale7.473,36525,13787,627Feb 22 04:30 PM
Carter Todd AlfredChief Scientific OfficerFeb 20 '24Sale7.686024,62390,992Feb 22 04:30 PM
Swartz RobinChief Operating OfficerJan 17 '24Sale7.152,54318,18272,327Jan 19 04:34 PM
Carter Todd AlfredChief Scientific OfficerJan 17 '24Sale7.181,2669,09053,094Jan 19 04:32 PM
PFREUNDSCHUH PETER P.Chief Financial OfficerOct 03 '23Sale6.9913,56794,833149,433Oct 05 04:41 PM
Carter Todd AlfredChief Scientific OfficerSep 15 '23Option Exercise2.855,00014,25064,860Sep 18 04:44 PM
Carter Todd AlfredChief Scientific OfficerSep 15 '23Sale8.1610,50085,68054,360Sep 18 04:44 PM